Updates are available Correction dated 2023-10-09
Click to view Correction: https://doi.org/10.1038/s41598-023-43747-x
-
Authors
Bao-Caamano, Aida
Costa-Fraga, Nicolás
Cayrefourcq, Laure
Jácome, María Amalia
Rodriguez-Casanova, Aitor
Muinelo-Romay, Laura
López-López, Rafael
Alix-Panabières, Catherine
Díaz-Lagares, Angel
- License Information
-
More Information
Article History
Received: 6 February 2023
Accepted: 4 September 2023
First Online: 16 September 2023
Change Date: 9 October 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41598-023-43747-x
Competing interests
: R.L.-L. has received honoraria for participation in Advisory Boards from Roche, AstraZeneca, Merck, Merck Sharp & Dohme, Bayer, Bristol-Myers Squibb, Novartis, Janssen, Lilly, Pfizer, and Leo; travel, accommodations, and expenses from PharmaMar, Roche, Bristol-Myers Squibb, and Pierre Fabre; research funding from Roche and Merck; and is co-founder and shareholder in Nasasbiotech, S.L., Mtrap Inc. The rest of the authors declare no potential conflicts of interest related to this article.
